Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 4
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Articles

High prevalence of nocturnal arterial hypertension and non-dipping in lung transplant recipients

Alexandra VandergheynstDept. of Endocrinology, Brussels, BelgiumCorrespondence[email protected]
, MD,
Philippe Van De BorneDept. of Cardiology, Brussels, Belgium
, PhD,
Christian MelotDept. of Emergency Medicine, Brussels, Belgium
, PhD , MD,
Christiane KnoopDept. of Chest Medicine, Brussels, Belgium
, PhD &
Marc LeemanHypertension Clinic, Erasme University Hospital, Brussels, Belgium
, PhD
Pages 395-400 | Received 20 May 2010, Accepted 27 May 2010, Published online: 23 May 2017

References

  • Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368–74.
  • Parati G, Staessen JA. Day-night blood pressure variations: mechanisms, reproducibility and clinical relevance. J Hyper-tens 2007; 25: 2377–80.
  • Boggia J, Li Y, Thijs L, Hansen T, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang J, Sandoya E, O’Brien E, Staessen JA. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370: 1219–29.
  • Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, De Bacquer DA. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51: 55–61.
  • van de Borne P, Leeman M, Primo G, Degaute JP. Reap-pearance of a normal circadian rhythm of blood pressure after cardiac transplantation. Am J Cardiol 1992; 69: 794–801.
  • Idema RN, van den Meiracker AH, Balk AH, Bos E, Schalekamp MA, Man in’t Veld AJ. Abnormal diurnal vari-ation of blood pressure, cardiac output and vascular resis-tance in cardiac transplant recipients. Circulation 1994; 90: 2797–803.
  • van de Borne P, Gelin M, Van de Stadt J, Degaute JP. Cir-cadian rhythms of blood pressure after liver transplantation. Hypertension 1993; 21: 398–405.
  • Covic A, Gusbeth-Tatomir P, Mardare N, Buhaescu I, Gold-smith DJA. Dynamics of the circadian blood pressure pro-files after renal transplantation. Transplantation 2005; 80: 1168.
  • Jenkins G, Singer D. Hypertension in thoracic transplant recipients. J Hum Hypertens 1998; 12: 813–23.
  • Trulock EP, Christie JD, Edwards LB, Boucek MM, Aurora P, Taylor DO, Dobbels F, Rahmel AO, Keck BM, Hertz ML. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report -2007. J Heart Lung Transplant 2007; 26: 782–95.
  • Silverborn M, Jeppsson A, Martensson G, Nilsson F. New-onset cardiovascular risk factors in lung transplant recipi-ents. J Heart Lung Transplant 2005; 24: 1536–43.
  • O’Brien E, Asmar R, Beilin L, Imai Y, Manion JM, Man-cia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure mea-surement. J Hypertens 2003; 21: 821–48.
  • Cuspidi C, Meani S, Salerno M, Valerio C, Fusi V, Sev-ergnini B, Lonati L, Magrini F, Zanchetti A. Cardiovascu-lar target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J Hypertens 2004; 22: 273–80.
  • Hernandez-del-Rey R, Martin-Baranera M, Sobrino J, Gorostidi M, Vinyoles E, Sierra C, Segura J, Coca A, Rui-lope LM. Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish Ambu-latory Blood Pressure Monitoring Registry. J Hypertens 2007; 25: 2406–12.
  • Berakis A, Williams T, Naughton M, Martin JH, Muhlmann M, Krumm H. Altered sympathetic and parasympathetic activity in lung transplantation patients at rest and follow-ing autonomic perturbation. Chest 2002; 122: 1192–9.
  • Lyson T, Ermel LD, Belshaw PJ, Alberg DG, Schreiber SL, Victor RG. Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. Circ Res 1993; 73: 596–602.
  • Malouf MA, Milrose MA, Grunstein RR, Wong K, Prashant T, Jankelson DM, Aboyoun CL, Bye PT, Glanville AR. Sleep-disordered breathing before and after lung trans-plantation. J Heart Lung Transplant 2008; 27: 540–6.
  • Uzu T, Ishikawa K, Fujii T, Nakamura S, Inenaga T, Kimura G. Sodium restriction shifts circadian rhythm of blood pres-sure from nondipper to dipper in essential hypertension. Circulation 1997; 96: 1859–62.
  • Uzu T, Kimura G. Diuretics shift circadian rythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999; 100: 1635–8.
  • Fukuda M, Yamanaka T, Mizuno M, Motokawa M, Shirasawa Y, Miyagi S, Nishio T, Yoshida A, Kimura G. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natri-uresis. J Hypertens 2008; 26: 583–8.
  • Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension 2001; 38: E28.
  • Hermida R, Calvo C, Ayala D, Fernández JR, Covelo M, Moj6n A, Lopez JE. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens 2005; 23: 1913–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.